Anlotinib is a small molecule multi-target tyrosine kinase inhibitor whose anti-tumor effects are inhibition of tumor growth and anti-tumor vasculature formation. Side effects such as hypertension, proteinuria, diarrhea, gastrointestinal reactions, liver function impairment, and bleeding can occur after taking Anrotinib. For the side effects of hypertension, you can consider adding blood pressure lowering drugs for treatment. Proteinuria can be considered with medications such as Bering capsules to reduce the formation of proteinuria. Patients with diarrhea may be considered for treatment with medications to stop diarrhea, gastrointestinal reactions are also treated for symptoms, and patients with bleeding may be considered for treatment to stop bleeding. Patients with hepatic impairment can be given medications to protect the liver. The side effects can all be relieved with symptomatic treatment. If the side effects of Anrotinib still cannot be relieved, you can consider reducing or stopping the medication.